Company news

Cardiff Oncology, Inc. news in 2023

Cardiff Oncology, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference

November 19, 2023

Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update

November 1, 2023

Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update

October 25, 2023

Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy

September 25, 2023

Cardiff Oncology to Present at Upcoming Investor Conferences in September

September 4, 2023

Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update

August 8, 2023

Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship

August 6, 2023

Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update

May 3, 2023

Cardiff Oncology Announces First Patient Dosed in ONSEMBLE Phase 2 Randomized Trial of Onvansertib in Patients with Metastatic Colorectal Cancer

March 27, 2023

Cardiff Oncology Formally Introduces Scientific Advisory Board

March 5, 2023

Cardiff Oncology Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

March 1, 2023

Cardiff Oncology to Present at the Cowen 43rd Annual Health Care Conference

February 26, 2023

Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer

February 1, 2023

Cardiff Oncology to Present at B. Riley Securities' 3rd Annual Oncology Conference

January 9, 2023

Calls in 2023

Decks in 2023